Skip to main content
Department of Pharmaceutics

Research Our research plan for the next 5 years (2019-2023):

Main research activities

Several active research groups in the department are engaged with different aspects of pharmaceutics. The research is directed towards high quality innovative topics aiming to publish applied articles.

The research plan in the period from 2019 till 2023 is still focusing on three distinct areas:

  1. Nanotechnology as a promising area of pharmaceutical science is a target for formulation of many drugs.
  2. Preformulation studies to improve the characteristics of drugs and/or dosage forms and development of more acceptable dosage forms.
  3. Targeted drug delivery systems 
# Title Research Year
1 Metformin hydrochloride laden nanostructured lipid carriers: A promising strategy for skin diseases 2025
2 Transdermal delivery of doxorubicin-loaded lyotropic liquid crystals formulations for enhanced drug skin deposition and cytotoxicity against MCF-7 breast cancer cells 2025
3 A green chemistry approach for preparation of metronidazole-zinc (ІІ) complexes: In vitro characterization, antimicrobial activity and promising cytotoxicity 2024
4 Prednisolone loaded-cationic nanoemulsion formulation for uveitis management 2024
5 Curcumin-loaded gold nanoparticles with enhanced antibacterial efficacy and wound healing properties in diabetic rats 2024
6 Rosuvastatin Flexible Chitosomes: Development, In Vitro Evaluation and Enhancement of Anticancer Efficacy Against HepG2 and MCF7 Cell Lines 2024
7 Sertaconazole-PLGA nanoparticles for management of ocular keratitis 2024
8 Impact of oil type on the development and oral bioavailability of self-nanoemulsifying drug delivery systems containing simvastatin 2024
9 Effective loading of incompatible drugs into nanosized vesicles: a strategy to allow concurrent administration of furosemide and midazolam in simulated clinical settings 2023
10 Serum levels of tumor necrosis factor (TNF-α) and vaginal gene expression of toll-like receptor 2 (TLR2) & microtubule-associated protein 1 light chain 3 (LC3) after treatment of vulvovaginal candidiasis with sertaconazole nitrate spanlastics 2023